A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia
- PMID: 11493466
- DOI: 10.1182/blood.v98.4.1166
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia
Abstract
The hematopoietic stem cell underlying acute myeloid leukemia (AML) is controversial. Flow cytometry and the DNA-binding dye Hoechst 33342 were previously used to identify a distinct subset of murine hematopoietic stem cells, termed the side population (SP), which rapidly expels Hoechst dye and can reconstitute the bone marrow of lethally irradiated mice. Here, the prevalence and pathogenic role of SP cells in human AML were investigated. Such cells were found in the bone marrow of more than 80% of 61 patients and had a predominant CD34(low/-) immunophenotype. Importantly, they carried cytogenetic markers of AML in all 11 cases of active disease examined and in 2 out of 5 cases in complete hematological remission. Comparison of daunorubicin and mitoxantrone fluorescence emission profiles revealed significantly higher drug efflux from leukemic SP cells than from non-SP cells. Three of 28 SP cell transplants generated overt AML-like disease in nonobese diabetic--severe combined immunodeficient mice. Low but persistent numbers of leukemic SP cells were detected by molecular and immunological assays in half of the remaining mice. Taken together, these findings indicate that SP cells are frequently involved in human AML and may be a target for leukemic transformation. They also suggest a mechanism by which SP cells could escape the effects of cytostatic drugs and might eventually contribute to leukemia relapse. (Blood. 2001;98:1166-1173)
Similar articles
-
Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.Blood. 2001 Jun 15;97(12):3882-9. doi: 10.1182/blood.v97.12.3882. Blood. 2001. PMID: 11389030
-
Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry.Blood. 1995 Apr 15;85(8):2147-53. Blood. 1995. PMID: 7536492
-
Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicin.Haematologica. 2000 Feb;85(2):124-32. Haematologica. 2000. PMID: 10681718
-
[Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].Folia Med Cracov. 2001;42(3):5-80. Folia Med Cracov. 2001. PMID: 12353422 Review. Polish.
-
A systematic overview of chemotherapy effects in acute myeloid leukaemia.Acta Oncol. 2001;40(2-3):231-52. doi: 10.1080/02841860151116321. Acta Oncol. 2001. PMID: 11441935 Review.
Cited by
-
Brain tumor stem cells: Molecular characteristics and their impact on therapy.Mol Aspects Med. 2014 Oct;39:82-101. doi: 10.1016/j.mam.2013.06.004. Epub 2013 Jul 4. Mol Aspects Med. 2014. PMID: 23831316 Free PMC article. Review.
-
EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.Mol Cancer Res. 2012 Aug;10(8):1098-108. doi: 10.1158/1541-7786.MCR-12-0086. Epub 2012 Jun 20. Mol Cancer Res. 2012. PMID: 22723308 Free PMC article.
-
Short-term repopulating cells with myeloid potential in human mobilized peripheral blood do not have a side population (SP) phenotype.Blood. 2006 Sep 15;108(6):2121-3. doi: 10.1182/blood-2006-03-013599. Epub 2006 May 30. Blood. 2006. PMID: 16735598 Free PMC article.
-
Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?MAbs. 2009 Jan-Feb;1(1):12-25. doi: 10.4161/mabs.1.1.7347. MAbs. 2009. PMID: 20046569 Free PMC article. Review.
-
ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug.Haematologica. 2009 Nov;94(11):1528-36. doi: 10.3324/haematol.2009.008631. Haematologica. 2009. PMID: 19880777 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical